Scanning ANPI Stock

Strong Uptrend
ANGIOTECH PHARMACEUTICALS (NASDAQ ANPI)
Smart Scan Chart Analysis confirms that a strong uptrend is in place and that the market remains positive longer term. Strong Uptrend with money management stops. A triangle indicates the presence of a very strong trend that is being driven by strong forces and insiders.

Get A Full FREE Trend Analysis for ANPI Here Sent To Your In-Box

May 27th Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX – News) has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS® Liberte® Atom(TM) Paclitaxel-Eluting Coronary Stent System, a highly deliverable, next-generation drug-eluting stent (DES) specifically designed for treating small coronary vessels. It was approved for use in vessels as small as 2.25 mm in diameter and joins the TAXUS® Express® Atom(TM) Stent as the only drug-eluting stents approved for small vessel use in the U.S. The Company plans to begin a full U.S. launch of TAXUS Liberte Atom next month.

Trend Analysis is a daily email analysis tool that gives me insight into exactly what my portfolio is doing. This link takes you to get your first symbol analyzed and from there you can easily add more symbols to get a daily update, which I find very helpful. There are only a few quality sites out there that provide FREE high quality trading tools.

Courtesy of The Market Guardian

Comment on this post below.